Europe Ostomy Care Market Research Report Forecast to 2030
The growth of the Europe ostomy care market is attributed to the technological advancements in ostomy care products, increasing awareness of ostomy care, and the growing prevalence of inflammatory bowel diseases. However, the availability of substitute therapies or products, and side effects after ostomy surgery are attributed to retarding market growth. Nonetheless, it is anticipated that the increasing number of product launches is creating lucrative opportunities for the Europe ostomy care market.
An ostomy is a surgically constructed stoma or artificial abdominal opening used to eliminate waste. The patient can evacuate waste products like urine, mucus, and feces by surgically rerouting a portion of the intestine through a hole (stoma) in the abdominal wall, such as by a colostomy, ileostomy, or urostomy. Moreover, Ostomy drainage bags or pouches are used to collect these wastes, and a range of ostomy accessories are utilized to hold the bag in place, halt leaks, and avoid causing skin irritation.
Market SegmentationBased on product, the Europe ostomy care market has been segmented into ostomy wafers, ostomy bags, and ostomy accessories.
The Europe ostomy care market, based on end users, has been segmented into hospitals & specialty clinics, home care settings, and ambulatory surgical centers.
The increase in the number of stoma patients due to Crohn's disease or ulcerative colitis, as well as rising awareness initiatives related to ostomy care or stoma surgical procedures, are factors driving the European market. According to the NCBI, IBD includes ulcerative colitis or Crohn's disease, and its prevalence is gradually increasing in European countries. Around 731,000 people in Europe have an ostomy, and IBD affects 0.3% of the total population. Due to the rising prevalence of renal diseases and kidney injuries, as well as the growing geriatric population, the UK is expected to dominate the market over the forecast period.
Major PlayersColoplast Corp (Denmark), Convatec Inc. (UK), and Hollister Incorporated (US), B. Braun Melsungen AG (Germany), Smith+Nephew (UK), 3M (US), Alcare Co., Ltd (Japan), CliniMed Limited (UK), Marlen Manufacturing & Development Company (US), Torbot Group, Inc (US).
Companies MentionedColoplast Corp (Denmark)
Convatec Inc. (UK)
and Hollister Incorporated (US)
B. Braun Melsungen AG (Germany)
Smith+Nephew (UK)
3M (US)
Alcare Co.
Ltd (Japan)
CliniMed Limited (UK)
Marlen Manufacturing & Development Company (US)
Torbot Group
Inc (US).
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.